The Lancet Neurology
Published: 19 Junio 2017
DOI: http://dx.doi.org/10.1016/S1474-4422(17)30179-5
Autor: Carsten Saft
Researchers are now harvesting the first fruits of their labour from nearly two decades of tremendous efforts to track progression of Huntington’s disease in the manifest and premanifest phases. Large observational studies such as PREDICT-HD,1 COHORT,2 REGISTRY,3 and TRACK-HD4 have aimed to find objective measures of disease progression and learn about the course of the disease.
